Presentation is loading. Please wait.

Presentation is loading. Please wait.

A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with Crizotinib  Trish Thorne-Nuzzo, BS, Crystal.

Similar presentations


Presentation on theme: "A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with Crizotinib  Trish Thorne-Nuzzo, BS, Crystal."— Presentation transcript:

1 A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with Crizotinib  Trish Thorne-Nuzzo, BS, Crystal Williams, MPH, Alice Catallini, BS, June Clements, MD, Shalini Singh, MD, James Amberson, MD, Kim Dickinson, MD, Zoran Gatalica, MD, Steffan N. Ho, MD, PhD, Isabell Loftin, PhD, Abigail McElhinny, PhD, Penny Towne, MBA  Journal of Thoracic Oncology  Volume 12, Issue 5, Pages (May 2017) DOI: /j.jtho Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

2 Figure 1 Outcome data for discordant cases. Abbreviations: ALK, anaplastic lymphoma kinase; FISH, fluorescence in situ hybridization; IHC, immunohistochemistry. Journal of Thoracic Oncology  , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

3 Figure 2 Patterns of anaplastic lymphoma kinase (ALK) immunohistochemistry (IHC) positivity in ALK IHC–positive/fluorescence in situ hybridization (FISH)–negative discordant cases. (A) ALK IHC–positive/ALK FISH-negative case displaying strong ALK IHC staining in more than 90% of tumor cells. (B) ALK IHC–positive/ALK FISH–negative case displaying heterogeneous ALK IHC staining intensity. Note diffusely distributed ALK-positive and ALK-negative tumor cells. (C) ALK IHC–positive/ALK FISH–negative case displaying heterogeneous ALK IHC staining. Note the distinct tumor areas of ALK-positive staining (right image) and ALK-negative staining (left image); areas of positivity may have been missed by FISH. Journal of Thoracic Oncology  , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions


Download ppt "A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with Crizotinib  Trish Thorne-Nuzzo, BS, Crystal."

Similar presentations


Ads by Google